Back
Monte Rosa Therapeutics Stock Predictions
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
21
GLUE
Monte Rosa Therapeutics
Last Price:
$6.92
Seasonality Move:
-3.94%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.Monte Rosa Therapeutics Stock Forecast
-
Over the next 52 weeks, Monte Rosa Therapeutics has on average historically fallen by 14.2% based on the past 3 years of stock performance.
-
Monte Rosa Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Monte Rosa Therapeutics Stock Undervalued?The current Monte Rosa Therapeutics [GLUE] share price is $6.91. The Score for GLUE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
GLUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Monte Rosa Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Monte Rosa Therapeutics has on average historically fallen by 14.2% based on the past 3 years of stock performance.
Monte Rosa Therapeutics Stock Rating
Sell
21
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics overpriced?
-
Monte Rosa Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Monte Rosa Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monterosatx.com
52-Week Data
52-Week High:
12.40
52-Week Low:
3.21
Prediction Charts
Market Cap:
424.5M
Price in USD:
6.91
Volume:
2.6M
Beta:
1.40
Technical Analysis
SMA50:
7.94
SMA100:
6.67
SMA200:
5.93
52-Wk Change:
27.96%
Stock Predictions
-
Is Monte Rosa Therapeutics stock public?Yes, Monte Rosa Therapeutics is a publicly traded company.
-
What is the Monte Rosa Therapeutics stock quote today?The Monte Rosa Therapeutics stock price is 6.91 USD today.
-
How to buy Monte Rosa Therapeutics stock online?You can buy Monte Rosa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 10.23 | 9.86 | 10.56 | 9.79 |
| Dec-4 | 9.98 | 9.24 | 10.17 | 8.82 |
| Dec-5 | 9.16 | 8.83 | 9.60 | 8.80 |
| Dec-6 | 8.92 | 9.41 | 9.88 | 8.92 |
| Dec-9 | 9.57 | 10.20 | 10.21 | 9.40 |
| Dec-10 | 10.00 | 9.44 | 10.69 | 9.40 |
| Dec-11 | 9.34 | 8.51 | 9.84 | 8.50 |
| Dec-12 | 8.48 | 7.79 | 8.58 | 7.66 |
| Dec-13 | 7.87 | 7.56 | 8.24 | 7.50 |
| Dec-16 | 7.53 | 7.68 | 7.93 | 7.36 |
| Dec-17 | 7.62 | 7.67 | 7.95 | 7.52 |
| Dec-18 | 7.67 | 7.03 | 7.89 | 6.89 |
| Dec-19 | 6.81 | 6.51 | 6.83 | 6.15 |
| Dec-20 | 6.44 | 6.91 | 7.14 | 6.41 |
Monte Rosa Therapeutics Earnings
Monte Rosa Therapeutics Earnings Report: Per Share Monte Rosa Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monte Rosa Therapeutics Forecast Revenue Growth
Monte Rosa Therapeutics Stock Analysis: Historical quarterly revenues per share for Monte Rosa Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.